Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

990
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
990
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

991
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
991
Chemical Synapses01:26

Chemical Synapses

8.9K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.9K
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

511
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
511
Chronic Pharyngitis01:23

Chronic Pharyngitis

2.7K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune-related markers define clinically relevant prognostic subgroups in thymic epithelial tumors.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

A single-cell atlas revealing cellular heterogeneity across healthy and diseased human thymus.

Nature communications·2026
Same author

A Delphi consensus on integrating novel therapies into the management of generalized myasthenia gravis.

Therapeutic advances in neurological disorders·2026
Same author

Vestibular and Ocular Motor Phenotype in a Case of Paraneoplastic Autoimmune Kelch-Like Protein-11 Encephalitis.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

High-Temperature Stable Amorphous Al<sub>2-<i>x</i></sub>(ZrY)<sub><i>x</i></sub>O<sub>3</sub> Thin Film Insulators: An Alternative to Crystalline Alumina.

ACS applied materials & interfaces·2026
Same author

Pulmonary Artery Sarcoma Study: A Multi-Centre European Society of Thoracic Surgeons Working Group Evaluating Diagnosis, Treatment, and Outcomes.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026

Related Experiment Video

Updated: Jul 17, 2025

Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation
08:35

Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation

Published on: December 29, 2014

16.7K

Thymectomy in myasthenia gravis.

Jakob Rath1, Bernhard Moser2,3, Fritz Zimprich1

  • 1Department of Neurology.

Current Opinion in Neurology
|August 28, 2023
PubMed
Summary

Thymectomy benefits myasthenia gravis patients, with lasting effects on clinical outcomes and reduced immunosuppression. Research continues to explore patient subgroups and biomarkers for optimal treatment selection.

More Related Videos

Real Time In Vivo Tracking of Thymocytes in the Anterior Chamber of the Eye by Laser Scanning Microscopy
08:21

Real Time In Vivo Tracking of Thymocytes in the Anterior Chamber of the Eye by Laser Scanning Microscopy

Published on: October 2, 2018

6.8K
Isolation and Transplantation of Different Aged Murine Thymic Grafts.
05:47

Isolation and Transplantation of Different Aged Murine Thymic Grafts.

Published on: May 13, 2015

13.9K

Related Experiment Videos

Last Updated: Jul 17, 2025

Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation
08:35

Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation

Published on: December 29, 2014

16.7K
Real Time In Vivo Tracking of Thymocytes in the Anterior Chamber of the Eye by Laser Scanning Microscopy
08:21

Real Time In Vivo Tracking of Thymocytes in the Anterior Chamber of the Eye by Laser Scanning Microscopy

Published on: October 2, 2018

6.8K
Isolation and Transplantation of Different Aged Murine Thymic Grafts.
05:47

Isolation and Transplantation of Different Aged Murine Thymic Grafts.

Published on: May 13, 2015

13.9K

Area of Science:

  • Neurology
  • Immunology
  • Surgical Science

Background:

  • Myasthenia gravis (MG) is an autoimmune disorder targeting acetylcholine receptors.
  • Thymectomy is a recognized treatment for MG, with proven efficacy in younger adults.
  • Long-term studies confirm sustained benefits of thymectomy, including improved clinical outcomes and decreased immunosuppression needs.

Approach:

  • Review of current literature on thymectomy for myasthenia gravis.
  • Focus on patient subgroups, predictive biomarkers, and surgical techniques.
  • Analysis of recent studies investigating outcomes in specific populations and minimally invasive approaches.

Key Points:

  • Thymectomy demonstrates persistent benefits for MG patients, reducing immunosuppressive therapy requirements.
  • Substantial patient proportions do not achieve stable remission, indicating ongoing peripheral autoimmune activity.
  • Limited outcome data exists for specific subgroups (e.g., >50 years, juvenile onset, ocular MG).
  • Biomarkers for patient selection are under investigation.
  • Minimally invasive techniques like robotic thymectomy show comparable outcomes to transsternal approaches with potentially fewer side effects.

Conclusions:

  • Thymectomy is an effective treatment for adult, early-onset, acetylcholine-receptor positive myasthenia gravis.
  • Further research is needed to clarify optimal treatment strategies for specific patient subgroups.
  • Ongoing investigations into biomarkers and surgical approaches aim to refine thymectomy's application.